PAR 6.67% 24.0¢ paradigm biopharmaceuticals limited..

General OA media and info, page-322

  1. 353 Posts.
    lightbulb Created with Sketch. 399
    10% at $6000 for treatment per year would be $600 BILLION in revenue

    Even 1% at $2500 a treatment per year would be $25 BILLION in revenue, which equates to $89 in revenue per share...

    Give me 0.1% of those patients at $2500 a share and I'll be happy. $8.90 revenue per share for a share currently priced at $0.66

    Amazing what we could be looking at in a matter of years.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.015(6.67%)
Mkt cap ! $83.98M
Open High Low Value Volume
22.5¢ 24.0¢ 22.5¢ $173.6K 743.6K

Buyers (Bids)

No. Vol. Price($)
8 99346 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 131244 5
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.